124 related articles for article (PubMed ID: 33142006)
1. Optimizing Precision of Hypertension Care to Maximize Blood Pressure Control: A Pilot Study Utilizing a Smartphone App to Incorporate Plasma Renin Activity Testing.
Mehanna M; Chen YE; Gong Y; Handberg E; Roth B; De Leon J; Smith SM; Harrell JG; Cooper-DeHoff RM
Clin Transl Sci; 2021 Mar; 14(2):617-624. PubMed ID: 33142006
[TBL] [Abstract][Full Text] [Related]
2. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
Mahmud A; Mahgoub M; Hall M; Feely J
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
[TBL] [Abstract][Full Text] [Related]
3. Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation.
Mahfoud F; Townsend RR; Kandzari DE; Kario K; Schmieder RE; Tsioufis K; Pocock S; David S; Patel K; Rao A; Walton A; Bloom JE; Weber T; Suppan M; Lauder L; Cohen SA; McKenna P; Fahy M; Böhm M; Weber MA
J Am Coll Cardiol; 2021 Jun; 77(23):2909-2919. PubMed ID: 33957242
[TBL] [Abstract][Full Text] [Related]
4. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.
Webster R; Salam A; de Silva HA; Selak V; Stepien S; Rajapakse S; Amarasekara S; Amarasena N; Billot L; de Silva AP; Fernando M; Guggilla R; Jan S; Jayawardena J; Maulik PK; Mendis S; Mendis S; Munasinghe J; Naik N; Prabhakaran D; Ranasinghe G; Thom S; Tisserra N; Senaratne V; Wijekoon S; Wijeyasingam S; Rodgers A; Patel A;
JAMA; 2018 Aug; 320(6):566-579. PubMed ID: 30120478
[TBL] [Abstract][Full Text] [Related]
5. Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated Hypertension.
Mehanna M; Wang Z; Gong Y; McDonough CW; Beitelshees AL; Gums JG; Chapman AB; Schwartz GL; Bailey KR; Johnson JA; Turner ST; Cooper-DeHoff RM
Am J Hypertens; 2019 Jun; 32(7):668-675. PubMed ID: 30753254
[TBL] [Abstract][Full Text] [Related]
6. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
[TBL] [Abstract][Full Text] [Related]
7. [Plasma Renin Activity and Potential of Indapamide Retard to Improve Control of Hypertension].
Kobalava ZhD; Kotovskaia IuV; Kravtsova OA
Kardiologiia; 2015; 55(2):21-6. PubMed ID: 26164984
[TBL] [Abstract][Full Text] [Related]
8. Association of a Smartphone Application With Medication Adherence and Blood Pressure Control: The MedISAFE-BP Randomized Clinical Trial.
Morawski K; Ghazinouri R; Krumme A; Lauffenburger JC; Lu Z; Durfee E; Oley L; Lee J; Mohta N; Haff N; Juusola JL; Choudhry NK
JAMA Intern Med; 2018 Jun; 178(6):802-809. PubMed ID: 29710289
[TBL] [Abstract][Full Text] [Related]
9. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
[TBL] [Abstract][Full Text] [Related]
10. Plasma renin activity testing to guide triple antirenin system drug therapy in a patient with difficult-to-treat hypertension.
Shah S; Coakley C; Hough A; Parra D
Ann Pharmacother; 2013 Nov; 47(11):1562-8. PubMed ID: 24285769
[TBL] [Abstract][Full Text] [Related]
11. The Use of Wireless, Smartphone App-Assisted Home Blood Pressure Monitoring Among Hypertensive Patients in Singapore: Pilot Randomized Controlled Trial.
Moon EW; Tan NC; Allen JC; Jafar TH
JMIR Mhealth Uhealth; 2019 May; 7(5):e13153. PubMed ID: 30905872
[TBL] [Abstract][Full Text] [Related]
12. Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).
McDonough CW; Magvanjav O; Sá ACC; El Rouby NM; Dave C; Deitchman AN; Kawaguchi-Suzuki M; Mei W; Shen Y; Singh RSP; Solayman M; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Webb A; Scherer SE; Sadee W; Turner ST; Cooper-DeHoff RM; Gong Y; Johnson JA
Circ Genom Precis Med; 2018 Apr; 11(4):e001854. PubMed ID: 29650764
[TBL] [Abstract][Full Text] [Related]
13. Plasma renin predicts success of antihypertensive drug withdrawal.
Ho GY; Blaufox MD; Wassertheil-Smoller S; Oberman A; Langford H
Am J Hypertens; 1994 Aug; 7(8):679-84. PubMed ID: 7986457
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension.
Andersen K; Weinberger MH; Constance CM; Ali MA; Jin J; Prescott MF; Keefe DL
J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):157-67. PubMed ID: 19617271
[TBL] [Abstract][Full Text] [Related]
15. Impact of a Culturally Tailored mHealth Medication Regimen Self-Management Program upon Blood Pressure among Hypertensive Hispanic Adults.
Chandler J; Sox L; Kellam K; Feder L; Nemeth L; Treiber F
Int J Environ Res Public Health; 2019 Apr; 16(7):. PubMed ID: 30959858
[No Abstract] [Full Text] [Related]
16. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of antihypertensive treatment based on plasma renin activity: An open label observational study.
Leotta G; Rabbia F; Testa E; Totaro S; Abram S; Milan A; Mulatero P; Veglio F
Blood Press; 2010 Aug; 19(4):218-24. PubMed ID: 20367559
[TBL] [Abstract][Full Text] [Related]
18. A mHealth-based care model for improving hypertension control in stroke survivors: Pilot RCT.
Lakshminarayan K; Westberg S; Northuis C; Fuller CC; Ikramuddin F; Ezzeddine M; Scherber J; Speedie S
Contemp Clin Trials; 2018 Jul; 70():24-34. PubMed ID: 29763657
[TBL] [Abstract][Full Text] [Related]
19. Aliskiren monotherapy results in the greatest and the least blood pressure lowering in patients with high- and low-baseline PRA levels, respectively.
Stanton AV; Dicker P; O'Brien ET
Am J Hypertens; 2009 Sep; 22(9):954-7. PubMed ID: 19556972
[TBL] [Abstract][Full Text] [Related]
20. Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension.
Nussberger J; Gradman AH; Schmieder RE; Lins RL; Chiang Y; Prescott MF
Int J Clin Pract; 2007 Sep; 61(9):1461-8. PubMed ID: 17590217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
